Fu'an Pharmaceutical (300194) March 10 Evening announcement, confirmed that the initial public offering price of 41.88 yuan/share, the corresponding P/e ratio is 46.02 times times. The company issued 33.4 million shares, of which 26.77 million shares on the Internet, for the distribution of the number of 80.15%, under the net placing 6.63 million shares, for the number of the distribution of 19.85%. March 14 implementation of the purchase. The company is mainly engaged in the development, production and sale of single ring-caprolactam, penicillin type, cephalosporins antibiotic raw material medicine and preparation. 2008 2010, the company realized operating income of 198 million yuan, 324 million yuan and 464 million yuan, the owner of the parent company's net profit is 45.699 million yuan, 90.6706 million yuan and 123 million yuan respectively. Responsible Editor: NF054
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.